Responses
Regular and young investigator award abstracts
Clinical trials completed
292 Immune checkpoint inhibitor induced overlapping cardiac and neuromuscular toxicities: Highlight of early diagnosis, early initiation of immunosuppressive therapy and multidisciplinary management
Compose a Response to This Article
Other responses
No responses have been published for this article.
